Healthcare, Technology, Consumer Staples Sep 08, 2021 07:08 PM (GMT+8) · EqualOcean
Cailian, September 8 (Xinhua) -- cubic pharmaceutical announced that it had received the acceptance notice of the drug registration application for oxycodone hydrochloride sustained-release tablets issued by the State Drug Administration. Oxycodone hydrochloride is an anesthetic used to relieve persistent moderate to severe pain.
Related companies: